Longitudinal changes in estimated and measured GFR in type 1 diabetes

Journal of the American Society of Nephrology

Volumn 25, Issue 4, 2014, Pages 810-818

  De Boer, Ian H ^a   Sun, Wanjie ^b   Cleary, Patricia A ^b   Lachin, John M ^b   Molitch, Mark E ^c   Zinman, Bernard ^d   Steffes, Michael W ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; HEMOGLOBIN A1C; IOTALAMIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEASURED ESTIMATED GLOMERULUS FILTRATION RATE; PRIORITY JOURNAL; BLOOD; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; PATHOPHYSIOLOGY;

ADULT; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MALE;

EID: 84901504239     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050557     Document Type: Article

References (23)

1. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
2. Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium: Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369: 932-943, 2013
3. Christiansen JS, Frandsen M, Parving HH: Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia 21: 368-373, 1981
4. Perkins BA, Ficociello LH, Roshan B, Warram JH, Krolewski AS: In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 77: 57-64, 2010
5. de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM; Diabetes Control and ComplicationsTrial/Epidemiology of Diabetes Interventions and Complications Study Research Group: Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171: 412-420, 2011
6. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS: Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 18: 1353-1361, 2007
7. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, de Boer IH, Zinman B, Lachin J; Epidemiology of Diabetes Interventions and Complications Study Group: Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33: 1536-1543, 2010
8. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
9. The Diabetes Control and Complications (DCCT) Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703-1720, 1995
10. Chudleigh RA, Ollerton RL, Dunseath G, Peter R, Harvey JN, Luzio S, Owens DR: Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia 52: 1274-1278, 2009
11. Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G: The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med 24: 443-448, 2007
12. Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH: Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-yearfollow-up study. J Am Soc Nephrol 16: 1404-1412, 2005
13. Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G: Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 31: 971-973, 2008
14. de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B; DCCT/EDIC Research Group: Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 365: 2366-2376, 2011
15. Hsu CY, Bansal N: Measured GFR as "gold standard"-all that glitters is not gold? Clin J Am Soc Nephrol 6: 1813-1814, 2011
16. Shlipak MG, Katz R, Kestenbaum B, Fried LF, Newman AB, Siscovick DS, Stevens L, Sarnak MJ: Rate of kidney function decline in older adults: A comparison using creatinine and cystatin C. Am J Nephrol 30: 171-178, 2009
17. White CA, Rule AD, Collier CP, Akbari A, Lieske JC, Lepage N, Doucette S, Knoll GA: The impact of interlaboratory differences in cystatin C assay measurement on glomerular filtration rate estimation. Clin J Am Soc Nephrol 6: 2150-2156, 2011
18. American Diabetes Association: Standards ofmedical care in diabetes-2013. Diabetes Care 36[Suppl 1]: S11-S66, 2013
19. KDOQI: KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49[Suppl 2]: S12-S154, 2007
20. DuBois D, DuBois E: A formula to estimate the approximate surface area ifheight and weight be known. Arch Intern Med17: 863-871, 1916
21. Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I; IFCC Working Group on Standardisation of Cystatin C (WG-SCC): First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 48: 1619-1621, 2010
22. Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer HM, Rohlfing C, England J, Bucksa J, Nowicki M: Hemoglobin A1 c measurements over nearly two decades: Sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem 51: 753-758, 2005
23. Efron B, Tibshirani R: An Introduction of the Bootstrap, New York, Chapman & Hall, 1993